HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Allogeneic bone marrow transplantation in a patient with T-prolymphocytic leukemia with small-intestinal involvement.

Abstract
Although T-prolymphocytic leukemia (T-PLL) is characterized by organ infiltration, small-intestinal involvement is rare. We performed an unrelated allogeneic bone marrow transplantation in a patient with T-PLL who had multiple lymphomatous polyposis of the small intestine refractory to combination chemotherapy (cyclophosphamide, vincristine, and prednisolone [COP] and fludarabine plus cyclophosphamide). The patient developed no graft-versus-host disease (GVHD) and remains in complete remission 16 months after the transplantation. T-PLL is usually refractory to chemotherapy and is a T-cell malignancy with poor prognosis. There have been several reports on allogeneic hematopoietic stem-cell transplantation (allo-HSCT) for T-PLL, but none on allo-HSCT for T-PLL patients with intestinal involvement. It is suggested that allo-HSCT may improve the prognosis in patients with T-PLL involving the small intestine.
AuthorsKazuyuki Murase, Takuya Matsunaga, Tsutomu Sato, Kageaki Kuribayashi, Katsuhisa Kogawa, Yutaka Kawano, Tetsuro Okamoto, Tetsuji Takayama, Hideki Watanabe, Yoshiro Niitsu, Yasuo Hirayama
JournalInternational journal of clinical oncology (Int J Clin Oncol) Vol. 8 Issue 6 Pg. 391-4 (Dec 2003) ISSN: 1341-9625 [Print] Japan
PMID14663643 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Vincristine
  • Cyclophosphamide
  • Vidarabine
  • fludarabine
  • Prednisone
Topics
  • Adult
  • Antineoplastic Combined Chemotherapy Protocols (administration & dosage, therapeutic use)
  • Bone Marrow Transplantation
  • Cyclophosphamide (administration & dosage)
  • Drug Resistance, Neoplasm
  • Humans
  • Intestinal Polyposis (etiology, pathology)
  • Leukemia, Prolymphocytic (complications, therapy)
  • Leukemia, T-Cell (complications, therapy)
  • Male
  • Prednisone (administration & dosage)
  • Transplantation, Homologous
  • Treatment Outcome
  • Vidarabine (administration & dosage, analogs & derivatives)
  • Vincristine (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: